nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofazimine—ABCB1—Mitomycin—urinary bladder cancer	0.225	0.289	CbGbCtD
Clofazimine—ABCB11—Doxorubicin—urinary bladder cancer	0.184	0.237	CbGbCtD
Clofazimine—CYP3A4—Thiotepa—urinary bladder cancer	0.102	0.131	CbGbCtD
Clofazimine—ABCB1—Gemcitabine—urinary bladder cancer	0.0647	0.0833	CbGbCtD
Clofazimine—ABCB1—Cisplatin—urinary bladder cancer	0.047	0.0605	CbGbCtD
Clofazimine—ABCB1—Etoposide—urinary bladder cancer	0.0462	0.0594	CbGbCtD
Clofazimine—ABCB1—Doxorubicin—urinary bladder cancer	0.0315	0.0405	CbGbCtD
Clofazimine—ABCB1—Methotrexate—urinary bladder cancer	0.0305	0.0393	CbGbCtD
Clofazimine—CYP3A4—Etoposide—urinary bladder cancer	0.0277	0.0356	CbGbCtD
Clofazimine—CYP3A4—Doxorubicin—urinary bladder cancer	0.0189	0.0243	CbGbCtD
Clofazimine—Ichthyosis—Fluorouracil—urinary bladder cancer	0.015	0.0673	CcSEcCtD
Clofazimine—Ichthyosis acquired—Fluorouracil—urinary bladder cancer	0.015	0.0673	CcSEcCtD
Clofazimine—Enteritis—Thiotepa—urinary bladder cancer	0.00612	0.0275	CcSEcCtD
Clofazimine—Cystitis noninfective—Valrubicin—urinary bladder cancer	0.00589	0.0265	CcSEcCtD
Clofazimine—Cystitis—Valrubicin—urinary bladder cancer	0.00583	0.0261	CcSEcCtD
Clofazimine—Bladder pain—Valrubicin—urinary bladder cancer	0.00546	0.0245	CcSEcCtD
Clofazimine—Hyperglycaemia—Valrubicin—urinary bladder cancer	0.00341	0.0153	CcSEcCtD
Clofazimine—Embolism—Thiotepa—urinary bladder cancer	0.00326	0.0146	CcSEcCtD
Clofazimine—Intestinal obstruction—Thiotepa—urinary bladder cancer	0.00307	0.0138	CcSEcCtD
Clofazimine—Hepatomegaly—Thiotepa—urinary bladder cancer	0.00295	0.0133	CcSEcCtD
Clofazimine—Thromboembolism—Epirubicin—urinary bladder cancer	0.00265	0.0119	CcSEcCtD
Clofazimine—Enteritis—Methotrexate—urinary bladder cancer	0.00263	0.0118	CcSEcCtD
Clofazimine—Thromboembolism—Doxorubicin—urinary bladder cancer	0.00245	0.011	CcSEcCtD
Clofazimine—Anaemia—Valrubicin—urinary bladder cancer	0.00244	0.0109	CcSEcCtD
Clofazimine—Drowsiness—Mitomycin—urinary bladder cancer	0.00233	0.0104	CcSEcCtD
Clofazimine—Skin discolouration—Thiotepa—urinary bladder cancer	0.00231	0.0104	CcSEcCtD
Clofazimine—Cystitis noninfective—Thiotepa—urinary bladder cancer	0.00204	0.00916	CcSEcCtD
Clofazimine—Cystitis—Thiotepa—urinary bladder cancer	0.00202	0.00906	CcSEcCtD
Clofazimine—Bladder pain—Thiotepa—urinary bladder cancer	0.00189	0.00848	CcSEcCtD
Clofazimine—Bone pain—Gemcitabine—urinary bladder cancer	0.00184	0.00824	CcSEcCtD
Clofazimine—Body temperature increased—Valrubicin—urinary bladder cancer	0.0017	0.00764	CcSEcCtD
Clofazimine—Anaemia—Mitomycin—urinary bladder cancer	0.00168	0.00754	CcSEcCtD
Clofazimine—Embolism venous—Epirubicin—urinary bladder cancer	0.00167	0.00749	CcSEcCtD
Clofazimine—Skin discolouration—Etoposide—urinary bladder cancer	0.00166	0.00746	CcSEcCtD
Clofazimine—Body temperature increased—Carboplatin—urinary bladder cancer	0.00158	0.00707	CcSEcCtD
Clofazimine—Asthenia—Valrubicin—urinary bladder cancer	0.00154	0.00693	CcSEcCtD
Clofazimine—Embolism venous—Doxorubicin—urinary bladder cancer	0.00154	0.00693	CcSEcCtD
Clofazimine—Pruritus—Valrubicin—urinary bladder cancer	0.00152	0.00684	CcSEcCtD
Clofazimine—Oedema—Mitomycin—urinary bladder cancer	0.00148	0.00666	CcSEcCtD
Clofazimine—Diarrhoea—Valrubicin—urinary bladder cancer	0.00147	0.00661	CcSEcCtD
Clofazimine—Dizziness—Valrubicin—urinary bladder cancer	0.00142	0.00639	CcSEcCtD
Clofazimine—Anorexia—Mitomycin—urinary bladder cancer	0.00141	0.00634	CcSEcCtD
Clofazimine—Embolism—Methotrexate—urinary bladder cancer	0.0014	0.00629	CcSEcCtD
Clofazimine—Vomiting—Valrubicin—urinary bladder cancer	0.00137	0.00614	CcSEcCtD
Clofazimine—Rash—Valrubicin—urinary bladder cancer	0.00136	0.00609	CcSEcCtD
Clofazimine—Dermatitis—Valrubicin—urinary bladder cancer	0.00136	0.00609	CcSEcCtD
Clofazimine—Headache—Valrubicin—urinary bladder cancer	0.00135	0.00605	CcSEcCtD
Clofazimine—Somnolence—Mitomycin—urinary bladder cancer	0.00132	0.00592	CcSEcCtD
Clofazimine—Embolism—Epirubicin—urinary bladder cancer	0.00131	0.00589	CcSEcCtD
Clofazimine—Decreased appetite—Mitomycin—urinary bladder cancer	0.00129	0.00579	CcSEcCtD
Clofazimine—Nausea—Valrubicin—urinary bladder cancer	0.00128	0.00574	CcSEcCtD
Clofazimine—Fatigue—Mitomycin—urinary bladder cancer	0.00128	0.00574	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Fluorouracil—urinary bladder cancer	0.00126	0.00563	CcSEcCtD
Clofazimine—Embolism—Doxorubicin—urinary bladder cancer	0.00121	0.00545	CcSEcCtD
Clofazimine—Neuralgia—Epirubicin—urinary bladder cancer	0.00121	0.00544	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Cisplatin—urinary bladder cancer	0.00119	0.00534	CcSEcCtD
Clofazimine—Hepatomegaly—Epirubicin—urinary bladder cancer	0.00119	0.00534	CcSEcCtD
Clofazimine—Hyperglycaemia—Thiotepa—urinary bladder cancer	0.00118	0.00531	CcSEcCtD
Clofazimine—Body temperature increased—Mitomycin—urinary bladder cancer	0.00117	0.00526	CcSEcCtD
Clofazimine—Hypokalaemia—Gemcitabine—urinary bladder cancer	0.00116	0.00521	CcSEcCtD
Clofazimine—Jaundice—Thiotepa—urinary bladder cancer	0.00114	0.00512	CcSEcCtD
Clofazimine—Neuralgia—Doxorubicin—urinary bladder cancer	0.00112	0.00503	CcSEcCtD
Clofazimine—Hepatomegaly—Doxorubicin—urinary bladder cancer	0.0011	0.00494	CcSEcCtD
Clofazimine—Hypokalaemia—Cisplatin—urinary bladder cancer	0.00108	0.00486	CcSEcCtD
Clofazimine—Eosinophilia—Fluorouracil—urinary bladder cancer	0.00107	0.00482	CcSEcCtD
Clofazimine—Asthenia—Mitomycin—urinary bladder cancer	0.00106	0.00478	CcSEcCtD
Clofazimine—Diarrhoea—Mitomycin—urinary bladder cancer	0.00101	0.00455	CcSEcCtD
Clofazimine—Skin discolouration—Methotrexate—urinary bladder cancer	0.000996	0.00447	CcSEcCtD
Clofazimine—Hyperglycaemia—Gemcitabine—urinary bladder cancer	0.000995	0.00447	CcSEcCtD
Clofazimine—Photosensitivity reaction—Fluorouracil—urinary bladder cancer	0.00099	0.00444	CcSEcCtD
Clofazimine—Dizziness—Mitomycin—urinary bladder cancer	0.000981	0.0044	CcSEcCtD
Clofazimine—Vomiting—Mitomycin—urinary bladder cancer	0.000943	0.00423	CcSEcCtD
Clofazimine—Rash—Mitomycin—urinary bladder cancer	0.000935	0.0042	CcSEcCtD
Clofazimine—Dermatitis—Mitomycin—urinary bladder cancer	0.000934	0.00419	CcSEcCtD
Clofazimine—Skin discolouration—Epirubicin—urinary bladder cancer	0.000932	0.00418	CcSEcCtD
Clofazimine—Headache—Mitomycin—urinary bladder cancer	0.000929	0.00417	CcSEcCtD
Clofazimine—Nausea—Mitomycin—urinary bladder cancer	0.000881	0.00395	CcSEcCtD
Clofazimine—Bone pain—Epirubicin—urinary bladder cancer	0.000879	0.00394	CcSEcCtD
Clofazimine—Cystitis noninfective—Methotrexate—urinary bladder cancer	0.000879	0.00394	CcSEcCtD
Clofazimine—Cystitis—Methotrexate—urinary bladder cancer	0.000868	0.0039	CcSEcCtD
Clofazimine—Skin discolouration—Doxorubicin—urinary bladder cancer	0.000862	0.00387	CcSEcCtD
Clofazimine—Anaemia—Thiotepa—urinary bladder cancer	0.000845	0.00379	CcSEcCtD
Clofazimine—Cystitis noninfective—Epirubicin—urinary bladder cancer	0.000822	0.00369	CcSEcCtD
Clofazimine—Jaundice—Etoposide—urinary bladder cancer	0.000819	0.00367	CcSEcCtD
Clofazimine—Bladder pain—Methotrexate—urinary bladder cancer	0.000813	0.00365	CcSEcCtD
Clofazimine—Bone pain—Doxorubicin—urinary bladder cancer	0.000813	0.00365	CcSEcCtD
Clofazimine—Cystitis—Epirubicin—urinary bladder cancer	0.000813	0.00365	CcSEcCtD
Clofazimine—Visual impairment—Cisplatin—urinary bladder cancer	0.000793	0.00356	CcSEcCtD
Clofazimine—Lymphadenopathy—Methotrexate—urinary bladder cancer	0.000765	0.00343	CcSEcCtD
Clofazimine—Bladder pain—Epirubicin—urinary bladder cancer	0.000761	0.00342	CcSEcCtD
Clofazimine—Cystitis noninfective—Doxorubicin—urinary bladder cancer	0.000761	0.00341	CcSEcCtD
Clofazimine—Cystitis—Doxorubicin—urinary bladder cancer	0.000752	0.00338	CcSEcCtD
Clofazimine—Lymphadenopathy—Epirubicin—urinary bladder cancer	0.000716	0.00321	CcSEcCtD
Clofazimine—Anorexia—Thiotepa—urinary bladder cancer	0.000711	0.00319	CcSEcCtD
Clofazimine—Anaemia—Gemcitabine—urinary bladder cancer	0.00071	0.00319	CcSEcCtD
Clofazimine—Bladder pain—Doxorubicin—urinary bladder cancer	0.000704	0.00316	CcSEcCtD
Clofazimine—Anaemia—Fluorouracil—urinary bladder cancer	0.000699	0.00314	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Methotrexate—urinary bladder cancer	0.000692	0.00311	CcSEcCtD
Clofazimine—Somnolence—Thiotepa—urinary bladder cancer	0.000663	0.00298	CcSEcCtD
Clofazimine—Lymphadenopathy—Doxorubicin—urinary bladder cancer	0.000663	0.00297	CcSEcCtD
Clofazimine—Anaemia—Cisplatin—urinary bladder cancer	0.000662	0.00297	CcSEcCtD
Clofazimine—Decreased appetite—Thiotepa—urinary bladder cancer	0.000648	0.00291	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Epirubicin—urinary bladder cancer	0.000648	0.00291	CcSEcCtD
Clofazimine—Fatigue—Thiotepa—urinary bladder cancer	0.000643	0.00289	CcSEcCtD
Clofazimine—Constipation—Thiotepa—urinary bladder cancer	0.000638	0.00286	CcSEcCtD
Clofazimine—Oedema—Gemcitabine—urinary bladder cancer	0.000627	0.00282	CcSEcCtD
Clofazimine—Oedema—Fluorouracil—urinary bladder cancer	0.000617	0.00277	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Epirubicin—urinary bladder cancer	0.000611	0.00274	CcSEcCtD
Clofazimine—Anaemia—Etoposide—urinary bladder cancer	0.000607	0.00272	CcSEcCtD
Clofazimine—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.000599	0.00269	CcSEcCtD
Clofazimine—Anorexia—Gemcitabine—urinary bladder cancer	0.000598	0.00268	CcSEcCtD
Clofazimine—Body temperature increased—Thiotepa—urinary bladder cancer	0.00059	0.00265	CcSEcCtD
Clofazimine—Anorexia—Fluorouracil—urinary bladder cancer	0.000588	0.00264	CcSEcCtD
Clofazimine—Oedema—Cisplatin—urinary bladder cancer	0.000585	0.00262	CcSEcCtD
Clofazimine—Gastrointestinal haemorrhage—Doxorubicin—urinary bladder cancer	0.000565	0.00254	CcSEcCtD
Clofazimine—Eosinophilia—Methotrexate—urinary bladder cancer	0.000559	0.00251	CcSEcCtD
Clofazimine—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.000558	0.0025	CcSEcCtD
Clofazimine—Somnolence—Gemcitabine—urinary bladder cancer	0.000558	0.0025	CcSEcCtD
Clofazimine—Anorexia—Cisplatin—urinary bladder cancer	0.000557	0.0025	CcSEcCtD
Clofazimine—Hypokalaemia—Epirubicin—urinary bladder cancer	0.000556	0.0025	CcSEcCtD
Clofazimine—Somnolence—Fluorouracil—urinary bladder cancer	0.000548	0.00246	CcSEcCtD
Clofazimine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000545	0.00245	CcSEcCtD
Clofazimine—Fatigue—Gemcitabine—urinary bladder cancer	0.000541	0.00243	CcSEcCtD
Clofazimine—Constipation—Gemcitabine—urinary bladder cancer	0.000536	0.00241	CcSEcCtD
Clofazimine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000536	0.00241	CcSEcCtD
Clofazimine—Asthenia—Thiotepa—urinary bladder cancer	0.000535	0.0024	CcSEcCtD
Clofazimine—Pruritus—Thiotepa—urinary bladder cancer	0.000528	0.00237	CcSEcCtD
Clofazimine—Eosinophilia—Epirubicin—urinary bladder cancer	0.000523	0.00235	CcSEcCtD
Clofazimine—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.000516	0.00232	CcSEcCtD
Clofazimine—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000515	0.00231	CcSEcCtD
Clofazimine—Hypokalaemia—Doxorubicin—urinary bladder cancer	0.000515	0.00231	CcSEcCtD
Clofazimine—Anorexia—Etoposide—urinary bladder cancer	0.000511	0.00229	CcSEcCtD
Clofazimine—Diarrhoea—Thiotepa—urinary bladder cancer	0.00051	0.00229	CcSEcCtD
Clofazimine—Decreased appetite—Cisplatin—urinary bladder cancer	0.000508	0.00228	CcSEcCtD
Clofazimine—Drowsiness—Methotrexate—urinary bladder cancer	0.000503	0.00226	CcSEcCtD
Clofazimine—Depression—Methotrexate—urinary bladder cancer	0.000502	0.00225	CcSEcCtD
Clofazimine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000496	0.00223	CcSEcCtD
Clofazimine—Dizziness—Thiotepa—urinary bladder cancer	0.000493	0.00221	CcSEcCtD
Clofazimine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000488	0.00219	CcSEcCtD
Clofazimine—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000484	0.00217	CcSEcCtD
Clofazimine—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000482	0.00216	CcSEcCtD
Clofazimine—Weight decreased—Epirubicin—urinary bladder cancer	0.000478	0.00214	CcSEcCtD
Clofazimine—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.000476	0.00214	CcSEcCtD
Clofazimine—Somnolence—Etoposide—urinary bladder cancer	0.000476	0.00214	CcSEcCtD
Clofazimine—Vomiting—Thiotepa—urinary bladder cancer	0.000474	0.00213	CcSEcCtD
Clofazimine—Drowsiness—Epirubicin—urinary bladder cancer	0.000471	0.00211	CcSEcCtD
Clofazimine—Rash—Thiotepa—urinary bladder cancer	0.00047	0.00211	CcSEcCtD
Clofazimine—Dermatitis—Thiotepa—urinary bladder cancer	0.00047	0.00211	CcSEcCtD
Clofazimine—Headache—Thiotepa—urinary bladder cancer	0.000467	0.0021	CcSEcCtD
Clofazimine—Decreased appetite—Etoposide—urinary bladder cancer	0.000466	0.00209	CcSEcCtD
Clofazimine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000462	0.00207	CcSEcCtD
Clofazimine—Fatigue—Etoposide—urinary bladder cancer	0.000462	0.00207	CcSEcCtD
Clofazimine—Jaundice—Epirubicin—urinary bladder cancer	0.000459	0.00206	CcSEcCtD
Clofazimine—Constipation—Etoposide—urinary bladder cancer	0.000458	0.00206	CcSEcCtD
Clofazimine—Hepatitis—Methotrexate—urinary bladder cancer	0.000452	0.00203	CcSEcCtD
Clofazimine—Asthenia—Gemcitabine—urinary bladder cancer	0.00045	0.00202	CcSEcCtD
Clofazimine—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000446	0.002	CcSEcCtD
Clofazimine—Pruritus—Gemcitabine—urinary bladder cancer	0.000444	0.00199	CcSEcCtD
Clofazimine—Nausea—Thiotepa—urinary bladder cancer	0.000443	0.00199	CcSEcCtD
Clofazimine—Weight decreased—Doxorubicin—urinary bladder cancer	0.000442	0.00198	CcSEcCtD
Clofazimine—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000441	0.00198	CcSEcCtD
Clofazimine—Pruritus—Fluorouracil—urinary bladder cancer	0.000436	0.00196	CcSEcCtD
Clofazimine—Drowsiness—Doxorubicin—urinary bladder cancer	0.000436	0.00196	CcSEcCtD
Clofazimine—Visual impairment—Methotrexate—urinary bladder cancer	0.000435	0.00195	CcSEcCtD
Clofazimine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000429	0.00193	CcSEcCtD
Clofazimine—Jaundice—Doxorubicin—urinary bladder cancer	0.000425	0.00191	CcSEcCtD
Clofazimine—Body temperature increased—Etoposide—urinary bladder cancer	0.000423	0.0019	CcSEcCtD
Clofazimine—Hepatitis—Epirubicin—urinary bladder cancer	0.000423	0.0019	CcSEcCtD
Clofazimine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000422	0.00189	CcSEcCtD
Clofazimine—Asthenia—Cisplatin—urinary bladder cancer	0.00042	0.00188	CcSEcCtD
Clofazimine—Dizziness—Fluorouracil—urinary bladder cancer	0.000408	0.00183	CcSEcCtD
Clofazimine—Visual impairment—Epirubicin—urinary bladder cancer	0.000407	0.00183	CcSEcCtD
Clofazimine—Diarrhoea—Cisplatin—urinary bladder cancer	0.0004	0.0018	CcSEcCtD
Clofazimine—Vomiting—Gemcitabine—urinary bladder cancer	0.000399	0.00179	CcSEcCtD
Clofazimine—Rash—Gemcitabine—urinary bladder cancer	0.000396	0.00178	CcSEcCtD
Clofazimine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000395	0.00177	CcSEcCtD
Clofazimine—Headache—Gemcitabine—urinary bladder cancer	0.000393	0.00176	CcSEcCtD
Clofazimine—Vomiting—Fluorouracil—urinary bladder cancer	0.000392	0.00176	CcSEcCtD
Clofazimine—Hepatitis—Doxorubicin—urinary bladder cancer	0.000391	0.00176	CcSEcCtD
Clofazimine—Rash—Fluorouracil—urinary bladder cancer	0.000389	0.00175	CcSEcCtD
Clofazimine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000389	0.00174	CcSEcCtD
Clofazimine—Headache—Fluorouracil—urinary bladder cancer	0.000386	0.00173	CcSEcCtD
Clofazimine—Asthenia—Etoposide—urinary bladder cancer	0.000384	0.00173	CcSEcCtD
Clofazimine—Pruritus—Etoposide—urinary bladder cancer	0.000379	0.0017	CcSEcCtD
Clofazimine—Visual impairment—Doxorubicin—urinary bladder cancer	0.000377	0.00169	CcSEcCtD
Clofazimine—Nausea—Gemcitabine—urinary bladder cancer	0.000373	0.00167	CcSEcCtD
Clofazimine—Vomiting—Cisplatin—urinary bladder cancer	0.000372	0.00167	CcSEcCtD
Clofazimine—Rash—Cisplatin—urinary bladder cancer	0.000369	0.00165	CcSEcCtD
Clofazimine—Dermatitis—Cisplatin—urinary bladder cancer	0.000368	0.00165	CcSEcCtD
Clofazimine—Diarrhoea—Etoposide—urinary bladder cancer	0.000367	0.00165	CcSEcCtD
Clofazimine—Nausea—Fluorouracil—urinary bladder cancer	0.000366	0.00164	CcSEcCtD
Clofazimine—Anaemia—Methotrexate—urinary bladder cancer	0.000363	0.00163	CcSEcCtD
Clofazimine—Dizziness—Etoposide—urinary bladder cancer	0.000354	0.00159	CcSEcCtD
Clofazimine—Nausea—Cisplatin—urinary bladder cancer	0.000347	0.00156	CcSEcCtD
Clofazimine—Vomiting—Etoposide—urinary bladder cancer	0.000341	0.00153	CcSEcCtD
Clofazimine—Anaemia—Epirubicin—urinary bladder cancer	0.00034	0.00153	CcSEcCtD
Clofazimine—Rash—Etoposide—urinary bladder cancer	0.000338	0.00152	CcSEcCtD
Clofazimine—Dermatitis—Etoposide—urinary bladder cancer	0.000337	0.00151	CcSEcCtD
Clofazimine—Headache—Etoposide—urinary bladder cancer	0.000336	0.00151	CcSEcCtD
Clofazimine—Nausea—Etoposide—urinary bladder cancer	0.000318	0.00143	CcSEcCtD
Clofazimine—Anaemia—Doxorubicin—urinary bladder cancer	0.000315	0.00141	CcSEcCtD
Clofazimine—Anorexia—Methotrexate—urinary bladder cancer	0.000306	0.00137	CcSEcCtD
Clofazimine—Oedema—Epirubicin—urinary bladder cancer	0.0003	0.00135	CcSEcCtD
Clofazimine—Anorexia—Epirubicin—urinary bladder cancer	0.000286	0.00128	CcSEcCtD
Clofazimine—Somnolence—Methotrexate—urinary bladder cancer	0.000285	0.00128	CcSEcCtD
Clofazimine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000279	0.00125	CcSEcCtD
Clofazimine—Oedema—Doxorubicin—urinary bladder cancer	0.000278	0.00125	CcSEcCtD
Clofazimine—Fatigue—Methotrexate—urinary bladder cancer	0.000277	0.00124	CcSEcCtD
Clofazimine—Somnolence—Epirubicin—urinary bladder cancer	0.000267	0.0012	CcSEcCtD
Clofazimine—Anorexia—Doxorubicin—urinary bladder cancer	0.000265	0.00119	CcSEcCtD
Clofazimine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000261	0.00117	CcSEcCtD
Clofazimine—Fatigue—Epirubicin—urinary bladder cancer	0.000259	0.00116	CcSEcCtD
Clofazimine—Constipation—Epirubicin—urinary bladder cancer	0.000257	0.00115	CcSEcCtD
Clofazimine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000254	0.00114	CcSEcCtD
Clofazimine—Somnolence—Doxorubicin—urinary bladder cancer	0.000247	0.00111	CcSEcCtD
Clofazimine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000242	0.00108	CcSEcCtD
Clofazimine—Fatigue—Doxorubicin—urinary bladder cancer	0.00024	0.00108	CcSEcCtD
Clofazimine—Constipation—Doxorubicin—urinary bladder cancer	0.000238	0.00107	CcSEcCtD
Clofazimine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000237	0.00107	CcSEcCtD
Clofazimine—Asthenia—Methotrexate—urinary bladder cancer	0.00023	0.00103	CcSEcCtD
Clofazimine—Pruritus—Methotrexate—urinary bladder cancer	0.000227	0.00102	CcSEcCtD
Clofazimine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.00022	0.000986	CcSEcCtD
Clofazimine—Diarrhoea—Methotrexate—urinary bladder cancer	0.00022	0.000985	CcSEcCtD
Clofazimine—Asthenia—Epirubicin—urinary bladder cancer	0.000215	0.000967	CcSEcCtD
Clofazimine—Pruritus—Epirubicin—urinary bladder cancer	0.000212	0.000954	CcSEcCtD
Clofazimine—Dizziness—Methotrexate—urinary bladder cancer	0.000212	0.000952	CcSEcCtD
Clofazimine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000205	0.000922	CcSEcCtD
Clofazimine—Vomiting—Methotrexate—urinary bladder cancer	0.000204	0.000916	CcSEcCtD
Clofazimine—Rash—Methotrexate—urinary bladder cancer	0.000202	0.000908	CcSEcCtD
Clofazimine—Dermatitis—Methotrexate—urinary bladder cancer	0.000202	0.000907	CcSEcCtD
Clofazimine—Headache—Methotrexate—urinary bladder cancer	0.000201	0.000902	CcSEcCtD
Clofazimine—Asthenia—Doxorubicin—urinary bladder cancer	0.000199	0.000895	CcSEcCtD
Clofazimine—Dizziness—Epirubicin—urinary bladder cancer	0.000199	0.000891	CcSEcCtD
Clofazimine—Pruritus—Doxorubicin—urinary bladder cancer	0.000197	0.000882	CcSEcCtD
Clofazimine—Vomiting—Epirubicin—urinary bladder cancer	0.000191	0.000857	CcSEcCtD
Clofazimine—Nausea—Methotrexate—urinary bladder cancer	0.000191	0.000856	CcSEcCtD
Clofazimine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00019	0.000853	CcSEcCtD
Clofazimine—Rash—Epirubicin—urinary bladder cancer	0.000189	0.00085	CcSEcCtD
Clofazimine—Dermatitis—Epirubicin—urinary bladder cancer	0.000189	0.000849	CcSEcCtD
Clofazimine—Headache—Epirubicin—urinary bladder cancer	0.000188	0.000844	CcSEcCtD
Clofazimine—Dizziness—Doxorubicin—urinary bladder cancer	0.000184	0.000825	CcSEcCtD
Clofazimine—Nausea—Epirubicin—urinary bladder cancer	0.000178	0.000801	CcSEcCtD
Clofazimine—Vomiting—Doxorubicin—urinary bladder cancer	0.000177	0.000793	CcSEcCtD
Clofazimine—Rash—Doxorubicin—urinary bladder cancer	0.000175	0.000786	CcSEcCtD
Clofazimine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000175	0.000786	CcSEcCtD
Clofazimine—Headache—Doxorubicin—urinary bladder cancer	0.000174	0.000781	CcSEcCtD
Clofazimine—Nausea—Doxorubicin—urinary bladder cancer	0.000165	0.000741	CcSEcCtD
